Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
This email address is used for sending the document.